Page de couverture de The Mortar & Pestle

The Mortar & Pestle

The Mortar & Pestle

Auteur(s): PCCA - The Leader in Compounding Pharmacy
Écouter gratuitement

À propos de cet audio

A podcast for pharmacy focusing on compounding personalized medicine, nutrition, marketing your business, and all things pharmacy..Copyright 2022 All rights reserved. Chimie Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Navigating Testosterone, Stress & Wellness with Ranel Larsen
    Sep 4 2025

    In this episode of The Mortar & Pestle Podcast, pharmacist and hormone therapy expert Ranel Larsen joins Mike de Lisio, Vice President of North American Sales, and Sebastian Denison, Clinical Compounding Pharmacist, RPh, FAARM (Candidate), to dig into men’s health. From hormone replacement therapy and lab testing to lifestyle factors like stress, sleep, and nutrition, Ranel breaks down how pharmacists can better support male patients while debunking common myths around testosterone.

    Voir plus Voir moins
    46 min
  • Live from the 2025 PCCA Technician Summit with Tiffany Kofroth, CSPT, CPhT-Adv & Mindy Stephens
    Aug 21 2025

    In this special live episode of Tech Talk, a Mortar & Pestle production, Erin Michael, Director of Member Engagement, is joined by Tiffany Kofroth, CSPT, CPhT-Adv, Advanced Pharmacy Technician in Continuing Pharmacy Education at the University of Texas at MD Anderson Cancer Center from and Mindy Stephens, as they discuss their compounding journeys.

    Voir plus Voir moins
    46 min
  • SubMagna® HMW with Richie Ray
    Aug 7 2025

    In this episode of The Mortar & Pestle: A PCCA Podcast, host Mike de Lisio is joined by PCCA’s VP of R&D, Daniel Banov, and returning guest Richie Ray, owner of Richie Specialty Pharmacy, to explore the innovation and impact of SubMagna—a proprietary sublingual base developed by PCCA. They discuss the technical challenges and scientific breakthroughs involved in formulating SubMagna to effectively deliver high molecular weight peptides like semaglutide via the sublingual route. Daniel details the base’s development process, including surfactant balancing, solubility enhancement, and permeability optimization, while Richie shares clinical insights, patient responses, and the broader market implications. Together, they highlight SubMagna’s potential as a game-changing delivery system for peptides and other challenging APIs, especially in an era of rising demand for non-injectable therapies.

    Voir plus Voir moins
    45 min
Pas encore de commentaire